Kezar Life Sciences announced the termination of Phase 2b PALIZADE clinical trial of zetomipzomib, an investigational therapy ...
Hay muchas maneras diferentes de educar a los niños y adolescentes recién diagnosticados sobre el lupus. Independientemente de cómo elija comunicarse, asegúrese de que lo que diga sea apropiado para ...
The Lupus Foundation of America (LFA) is excited to announce Karen Costenbader is the recipient of the LFA’s 2024 Predict and Prevent Lupus Research grant.
The Lupus Foundation of America (LFA) created the Predict and Prevent Lupus Research grant in 2024 to support innovative research aimed at identifying people at high risk for lupus and ultimately ...
Use your power! Find your walk and register your team today. Fundraise We provide you with all the tools you need to fundraise for lupus research, support and education services all while earning ...
Karen Costenbader, MD, MPH, is a rheumatologist and translational epidemiologist, whose research has focused on translational and clinical studies and trials in systemic lupus erythematosus (lupus or ...
Algunos individuos con lupus podrán encontrar que su enfermedad ha afectado su capacidad (o la de un ser querido) de financiar su educación después de la escuela secundaria. Obtenga más información ...
The unpredictability of lupus can be overwhelming at times, especially when attempting to navigate a maze-like healthcare system. It is important to know how to self-advocate by knowing your rights ...
Cheryl Russell of Highland Beach, FL, doesn’t indulge in what she calls “symptom chasing.” After more than three decades with lupus, she refuses to head to the doctor every time she has joint pain or ...
Through comprehensive programs of research, education, support and advocacy, we lead the fight to improve the quality of life for all people affected by lupus. Lupus is a complex disease that requires ...
The PALIZADE clinical study is evaluating zetomipzomib for the treatment of lupus nephritis, its side effects, and how it affects proteins in the urine. The PALIZADE clinical trial is made up of 3 ...